Medtronic PLC (MDT) Enterprise Value (EV): $135 Billion

Since April 30th, 2009, Medtronic PLC's enterprise value (ev) has increased from $38.4 Billion to $135 Billion at September 6th, 2024.

From 2009 to 2024 Medtronic PLC's highest enterprise value (ev) was $179 Billion
Medtronic PLC's lowest enterprise value (ev) during that period was $35.8 Billion
Medtronic PLC's average enterprise value (ev) from 2009 to 2024 Medtronic PLC's was $107 Billion

Medtronic PLC's enterprise value (ev) as of September 6th, 2024 of $135 Billion was higher than its peers in the Medical Appliances & Equipment industry group of August 31st, 2024 of 2.74 Billion. From April 30th, 2009 to September 6th, 2024, Medtronic PLC's average enterprise value (ev) was 107 Billion compared to an industry average of 3.94 Billion.

About Medtronic PLC

Medtronic Plc is engaged in the medical technology-alleviating pain, restoring health, and extending life for millions of people around the world. Its customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. The company operates through four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group consist of three divisions : Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group consists of two divisions: Surgical Solutions and Patient Monitoring and Recovery. The Restorative Therapies Group consists of four divisions: Spine, Neuromodulation, Surgical Technologies and Neurovascular. The Diabetes Group consists of three divisions: Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.